Treatment with cisplatin alone did not show any significant (P < 0.05) change in elevated serum insulin levels; however, treatment with combination of cisplatin with telmisartan produced significant (P < 0.05) decrease in elevated serum insulin levels in cancer treated rats (Figure 2(b)). This evidence concerns the gene INS and cancer.